Let's have one more look on the potential power of dynamic susceptibility contrast MRI: time, space, and vascular habitats in locally recurrent high-grade gliomas.
作者信息
Pascuzzo Riccardo, Doniselli Fabio M, Moscatelli Marco E M
机构信息
Neuroradiology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133, Milan, Italy.
Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.
出版信息
Eur Radiol. 2024 Mar;34(3):1979-1981. doi: 10.1007/s00330-023-10271-5. Epub 2023 Oct 5.
Abstract
摘要
相似文献
1
Let's have one more look on the potential power of dynamic susceptibility contrast MRI: time, space, and vascular habitats in locally recurrent high-grade gliomas.让我们再看一看动态磁敏感对比增强磁共振成像的潜在作用：局部复发性高级别胶质瘤中的时间、空间和血管环境。
Eur Radiol. 2024 Mar;34(3):1979-1981. doi: 10.1007/s00330-023-10271-5. Epub 2023 Oct 5.
2
Preoperative vascular heterogeneity based on dynamic susceptibility contrast MRI in predicting spatial pattern of locally recurrent high-grade gliomas.基于动态磁敏感对比 MRI 的术前血管异质性预测局部复发性高级别胶质瘤的空间模式。
Eur Radiol. 2024 Mar;34(3):1982-1993. doi: 10.1007/s00330-023-10149-6. Epub 2023 Sep 2.
3
Combined use of susceptibility weighted magnetic resonance imaging sequences and dynamic susceptibility contrast perfusion weighted imaging to improve the accuracy of the differential diagnosis of recurrence and radionecrosis in high-grade glioma patients.联合使用磁共振成像敏感性加权序列和动态磁敏感对比灌注加权成像以提高高级别胶质瘤患者复发与放射性坏死鉴别诊断的准确性。
Oncotarget. 2017 Mar 21;8(12):20340-20353. doi: 10.18632/oncotarget.13050.
4
Longitudinal DSC-MRI for Distinguishing Tumor Recurrence From Pseudoprogression in Patients With a High-grade Glioma.用于鉴别高级别胶质瘤患者肿瘤复发与假性进展的纵向动态对比增强磁共振成像
Am J Clin Oncol. 2017 Jun;40(3):228-234. doi: 10.1097/COC.0000000000000156.
5
Diffusion kurtosis imaging combined with dynamic susceptibility contrast-enhanced MRI in differentiating high-grade glioma recurrence from pseudoprogression.扩散峰度成像联合动态磁敏感对比增强 MRI 鉴别高级别胶质瘤复发与假性进展。
Eur J Radiol. 2021 Nov;144:109941. doi: 10.1016/j.ejrad.2021.109941. Epub 2021 Aug 31.
6
Tumor recurrence versus treatment effects in glioma: A comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging.胶质瘤中肿瘤复发与治疗效果的比较：三维伪连续动脉自旋标记与动态磁敏感对比成像的对比研究
Medicine (Baltimore). 2017 Dec;96(50):e9332. doi: 10.1097/MD.0000000000009332.
7
Diagnostic accuracy of dynamic contrast-enhanced perfusion MRI in stratifying gliomas: A systematic review and meta-analysis.动态对比增强磁共振灌注成像在胶质瘤分级中的诊断准确性：系统评价和荟萃分析。
Cancer Med. 2019 Sep;8(12):5564-5573. doi: 10.1002/cam4.2369. Epub 2019 Aug 7.
8
Dynamic contrast-enhanced MRI may be helpful to predict response and prognosis after bevacizumab treatment in patients with recurrent high-grade glioma: comparison with diffusion tensor and dynamic susceptibility contrast imaging.动态对比增强磁共振成像可能有助于预测复发性高级别胶质瘤患者贝伐单抗治疗后的反应和预后：与弥散张量和动态磁敏感对比成像的比较。
Neuroradiology. 2021 Nov;63(11):1811-1822. doi: 10.1007/s00234-021-02693-z. Epub 2021 Mar 23.
9
Prospective trial evaluating the sensitivity and specificity of 3,4-dihydroxy-6-[18F]-fluoro-L-phenylalanine (18F-DOPA) PET and MRI in patients with recurrent gliomas.前瞻性试验评估 3,4-二羟基-6-[18F]-氟-L-苯丙氨酸 (18F-DOPA) PET 和 MRI 在复发性脑胶质瘤患者中的敏感性和特异性。
J Neurooncol. 2018 May;137(3):583-591. doi: 10.1007/s11060-018-2750-7. Epub 2018 Jan 13.
10
Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.O-(2-[18F]-氟乙基)-L-酪氨酸-正电子发射断层扫描成像对低级别胶质瘤患者组织病理学特征及无进展生存期的预后价值
World Neurosurg. 2016 May;89:230-9. doi: 10.1016/j.wneu.2016.01.085. Epub 2016 Mar 9.
本文引用的文献
1
Preoperative vascular heterogeneity based on dynamic susceptibility contrast MRI in predicting spatial pattern of locally recurrent high-grade gliomas.基于动态磁敏感对比 MRI 的术前血管异质性预测局部复发性高级别胶质瘤的空间模式。
Eur Radiol. 2024 Mar;34(3):1982-1993. doi: 10.1007/s00330-023-10149-6. Epub 2023 Sep 2.
2
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.2021 年世卫组织中枢神经系统肿瘤分类：概述。
Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106.
3
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.成人脑胶质母细胞瘤：神经肿瘤学会（SNO）和欧洲神经肿瘤学会（EANO）关于当前管理和未来方向的共识综述。
Neuro Oncol. 2020 Aug 17;22(8):1073-1113. doi: 10.1093/neuonc/noaa106.
4
Imaging of intratumoral heterogeneity in high-grade glioma.高级别胶质瘤瘤内异质性的影像学表现。
Cancer Lett. 2020 May 1;477:97-106. doi: 10.1016/j.canlet.2020.02.025. Epub 2020 Feb 27.
5
Glioblastoma: Vascular Habitats Detected at Preoperative Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging Predict Survival.胶质母细胞瘤：术前动态磁敏感对比增强灌注磁共振成像检测到的血管生境可预测生存。
Radiology. 2018 Jun;287(3):944-954. doi: 10.1148/radiol.2017170845. Epub 2018 Jan 19.
6
MRI in Glioma Immunotherapy: Evidence, Pitfalls, and Perspectives.MRI 在神经胶质瘤免疫治疗中的应用：证据、陷阱与展望。
J Immunol Res. 2017;2017:5813951. doi: 10.1155/2017/5813951. Epub 2017 Apr 20.
7
Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma.肿瘤内异质性：导致人类胶质母细胞瘤治疗耐药和复发的途径。
Ann Oncol. 2017 Jul 1;28(7):1448-1456. doi: 10.1093/annonc/mdx169.
8
Dynamic Susceptibility Contrast MR Imaging in Glioma: Review of Current Clinical Practice.胶质瘤的动态磁敏感对比磁共振成像：当前临床实践综述
Magn Reson Imaging Clin N Am. 2016 Nov;24(4):649-670. doi: 10.1016/j.mric.2016.06.005. Epub 2016 Sep 14.
9
Clinical benefit from resection of recurrent glioblastomas: results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection.复发性胶质母细胞瘤切除的临床获益：一项多中心研究结果，该研究纳入了503例接受手术切除的复发性胶质母细胞瘤患者。
Neuro Oncol. 2016 Jan;18(1):96-104. doi: 10.1093/neuonc/nov145. Epub 2015 Aug 4.
10
The influence of surgery on recurrence pattern of glioblastoma.手术对胶质母细胞瘤复发模式的影响。
Clin Neurol Neurosurg. 2013 Jan;115(1):37-43. doi: 10.1016/j.clineuro.2012.04.005. Epub 2012 Apr 24.
Zotero 插件